Zhihai Si

1.7k total citations
19 papers, 1.4k citations indexed

About

Zhihai Si is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Zhihai Si has authored 19 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Virology, 11 papers in Immunology and 8 papers in Infectious Diseases. Recurrent topics in Zhihai Si's work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (8 papers) and Immune Cell Function and Interaction (8 papers). Zhihai Si is often cited by papers focused on HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (8 papers) and Immune Cell Function and Interaction (8 papers). Zhihai Si collaborates with scholars based in United States. Zhihai Si's co-authors include Joseph Sodroski, C. Martin Stoltzfus, Brad A. Amendt, Matthew Stremlau, Felipe Diaz‐Griffero, Hassan Javanbakht, Navid Madani, Ngoc Phan, Amos B. Smith and Liping Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Zhihai Si

18 papers receiving 1.4k citations

Peers

Zhihai Si
M A Martin United States
George M. Shaw United States
Raiees Andrabi United States
Beatriz Pacheco United States
S A Tilley United States
I S Chen United States
Elena Sokolskaja United States
Simone Cowan United States
M A Martin United States
Zhihai Si
Citations per year, relative to Zhihai Si Zhihai Si (= 1×) peers M A Martin

Countries citing papers authored by Zhihai Si

Since Specialization
Citations

This map shows the geographic impact of Zhihai Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhihai Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhihai Si more than expected).

Fields of papers citing papers by Zhihai Si

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhihai Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhihai Si. The network helps show where Zhihai Si may publish in the future.

Co-authorship network of co-authors of Zhihai Si

This figure shows the co-authorship network connecting the top 25 collaborators of Zhihai Si. A scholar is included among the top collaborators of Zhihai Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhihai Si. Zhihai Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Żuk, Anna, Zhihai Si, Debie J. Hoivik, et al.. (2022). Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia. Journal of Pharmacology and Experimental Therapeutics. 383(1). 11–24. 17 indexed citations
2.
Densen, Peter, Laynez W. Ackermann, Leslie Saucedo, et al.. (2020). A Point Mutation Creating a 3′ Splice Site in C8A Is a Predominant Cause of C8α-γ Deficiency in African Americans. The Journal of Immunology. 205(6). 1535–1539.
3.
Haim, Hillel, Zhihai Si, Navid Madani, et al.. (2009). Soluble CD4 and CD4-Mimetic Compounds Inhibit HIV-1 Infection by Induction of a Short-Lived Activated State. PLoS Pathogens. 5(4). e1000360–e1000360. 139 indexed citations
4.
Li, Xing, Bert Gold, Colm Ó’hUigín, et al.. (2006). Unique features of TRIM5α among closely related human TRIM family members. Virology. 360(2). 419–433. 60 indexed citations
5.
Diaz‐Griffero, Felipe, Nick Vandegraaff, Yuan Li, et al.. (2006). Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1. Virology. 351(2). 404–419. 82 indexed citations
6.
Si, Zhihai, Nick Vandegraaff, Colm Ó’hUigín, et al.. (2006). Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection. Proceedings of the National Academy of Sciences. 103(19). 7454–7459. 73 indexed citations
7.
Herrera, Carolina, Per Johan Klasse, Elizabeth Michael, et al.. (2005). The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles. Virology. 338(1). 154–172. 67 indexed citations
8.
Javanbakht, Hassan, Felipe Diaz‐Griffero, Matthew Stremlau, Zhihai Si, & Joseph Sodroski. (2005). The Contribution of RING and B-box 2 Domains to Retroviral Restriction Mediated by Monkey TRIM5α. Journal of Biological Chemistry. 280(29). 26933–26940. 148 indexed citations
9.
Xiang, Shi-Hua, Michael Farzan, Zhihai Si, et al.. (2005). Functional Mimicry of a Human Immunodeficiency Virus Type 1 Coreceptor by a Neutralizing Monoclonal Antibody. Journal of Virology. 79(10). 6068–6077. 30 indexed citations
10.
Javanbakht, Hassan, Byeongwoon Song, Felipe Diaz‐Griffero, et al.. (2005). Retroviral Restriction Factor TRIM5α Is a Trimer. Journal of Virology. 79(22). 14446–14450. 110 indexed citations
11.
Si, Zhihai, Paul R. Gorry, Christopher M. Owens, et al.. (2004). Envelope Glycoprotein Determinants of Increased Entry in a Pathogenic Simian–Human Immunodeficiency Virus (SHIV-HXBc2P 3.2) Passaged in Monkeys. AIDS Research and Human Retroviruses. 20(2). 163–173. 15 indexed citations
12.
Yuan, Wen, Stewart Craig, Zhihai Si, Michael Farzan, & Joseph Sodroski. (2004). CD4-Induced T-20 Binding to Human Immunodeficiency Virus Type 1 gp120 Blocks Interaction with the CXCR4 Coreceptor. Journal of Virology. 78(10). 5448–5457. 46 indexed citations
13.
Cocklin, Simon, Navid Madani, Zhihai Si, et al.. (2004). Mode of Action for Linear Peptide Inhibitors of HIV-1 gp120 Interactions. Biochemistry. 43(7). 1928–1938. 42 indexed citations
14.
Si, Zhihai, Navid Madani, Jason M. Cox, et al.. (2004). Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins. Proceedings of the National Academy of Sciences. 101(14). 5036–5041. 219 indexed citations
15.
Si, Zhihai, et al.. (2003). Effects of HIV Type 1 Envelope Glycoprotein Proteolytic Processing on Antigenicity. AIDS Research and Human Retroviruses. 19(3). 217–226. 43 indexed citations
16.
Si, Zhihai, Mark J. Cayabyab, & Joseph Sodroski. (2001). Envelope Glycoprotein Determinants of Neutralization Resistance in a Simian-Human Immunodeficiency Virus (SHIV-HXBc2P 3.2) Derived by Passage in Monkeys. Journal of Virology. 75(9). 4208–4218. 54 indexed citations
17.
Si, Zhihai, et al.. (1998). The Exon Splicing Silencer in Human Immunodeficiency Virus Type 1 Tat Exon 3 Is Bipartite and Acts Early in Spliceosome Assembly. Molecular and Cellular Biology. 18(9). 5404–5413. 66 indexed citations
19.
Amendt, Brad A., Zhihai Si, & C. Martin Stoltzfus. (1995). Presence of Exon Splicing Silencers within Human Immunodeficiency Virus Type 1 tat Exon 2 and tat-rev Exon 3: Evidence for Inhibition Mediated by Cellular Factors. Molecular and Cellular Biology. 15(8). 4606–4615. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026